InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Girao Tiago, Chief Financial Officer. Director active across 2 companies, notably Immunovant, Inc.. Cumulatively, 8 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €883k. History available since 1 May 2025. The latest transaction was filed on 23 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Girao Tiago
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
6,798 shares@ US$38.690.0032% mcap26.1% of flowCommon StockSEC:0001618670-26-000004:0
10,000 sharesCommon StockSEC:0001764013-26-000072:0
10,000 sharesCommon StockSEC:0001764013-26-000072:1
25,760 shares@ US$29.620.012% mcap50.0% of flowCommon StockSEC:0001764013-26-000056:0
64,968 shares0Common StockSEC:0001764013-26-000032:0
208,388 shares0Common StockSEC:0001415889-25-012047:0
35,250 sharesCommon StockSEC:0001140361-16-050458:0
35,250 sharesCommon StockSEC:0001140361-16-049631:0
8 of 8 declarations
About Girao Tiago
Tiago Girao is the Chief Financial Officer of Immunovant, Inc. He is responsible for financial management and strategy, playing a key role in the company's performance.
